It's beginning to look like the shorts will not be hindered by the generic settlement, A EU partner, or new application indications. The only thing that is going to take AVNR passed their influence is profitability. The more AVNR shows the ability to make money the higher the pps....and that is it. $20. per share is at least 3 years or more away, assuming no buyout first.
Really! Guess we can agree that we disagree! Based on Avanir's peer valuations we out to be near $10 now... Just take a look at ARNA's valuation well over 1 billion dollars and generates a lot lot less revenue than Avanir as they receive only a percentage of the total revenue... Once the generic resolution uncertainty cloud has passed look out upside. But then again I am long Avanir and have a Favorable opinion. It sure would be nice if every poster disclosed their interest!
I am patiently long, hoping for more but shorty's influence is strong and pockets are deep. They are not stupid. They know there is more money to be made shorting AVNR. They will let us know when they are finished!!
Yes...I FULLY AGREE.
They have always been expected to win the Generic litigation by virtually every analyst.
Longs are setting themselves up for another round of disappointment when the share price doesn't spike nearly as high as they think on a favorable settlement. Look for a rapid decline in share price shortly after the brief spike upon decision. MANY WILL SELL ON THE NEWS AND RIGHt FULLY SO